FDA official logo
GSRS logoPFDA official logo

SOTROVIMAB

UNII:1MTK0BPN8V
Formula:
Preferred Substance Name:SOTROVIMAB

  • 2423014-07-5
  • GSK4182136
  • GSK-4182136
  • IMMUNOGLOBULIN G1 (438-LEUCINE,444-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VIR-7831 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIR-7831 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2)),HUMAN MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-457) (HOMO SAPIENS VH (IGHV1-18*01 (93%) (IGHD)-IGHJ5*01 (93%)) (8.8.20) (1-127)-HOMO SAPIENS IGHG1*01 (CH3(M88>L(438), N94>S(444)) (128-457)) (230-214')- DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-20*01 (94%) IGKJ4*01)(7.3.8) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (236-236'':239-239'')-BISDISULFIDE. POST-TRANSLATIONAL MODIFICATIONS: K (457) AND K (457'') DELETED, N (307) AND N (307'') GLYCOSYLATED
  • SOTROVIMAB [INN]
  • SOTROVIMAB [JAN]
  • SOTROVIMAB [USAN]
  • SOTROVIMAB [WHO-DD]
  • VIR7831
  • VIR-7831



UNII - 1MTK0BPN8V | UNII Search Service